BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 17409269)

  • 1. Sickle cell trait and the risk of venous thromboembolism among blacks.
    Austin H; Key NS; Benson JM; Lally C; Dowling NF; Whitsett C; Hooper WC
    Blood; 2007 Aug; 110(3):908-12. PubMed ID: 17409269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of sickle cell trait and venous thromboembolism incidence.
    Folsom AR; Tang W; Roetker NS; Kshirsagar AV; Derebail VK; Lutsey PL; Naik R; Pankow JS; Grove ML; Basu S; Key NS; Cushman M
    J Thromb Haemost; 2015 Jan; 13(1):2-9. PubMed ID: 25393788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal contraception, sickle cell trait, and risk for venous thromboembolism among African American women.
    Austin H; Lally C; Benson JM; Whitsett C; Hooper WC; Key NS
    Am J Obstet Gynecol; 2009 Jun; 200(6):620.e1-3. PubMed ID: 19306959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of sickle cell trait on the thrombotic risk associated with non-O blood groups in northern Nigeria.
    Ahmed SG; Kagu MB; Ibrahim UA; Bukar AA
    Blood Transfus; 2015 Oct; 13(4):639-43. PubMed ID: 26057489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sickle cell trait is not independently associated with susceptibility to end-stage renal disease in African Americans.
    Hicks PJ; Langefeld CD; Lu L; Bleyer AJ; Divers J; Nachman PH; Derebail VK; Bowden DW; Freedman BI
    Kidney Int; 2011 Dec; 80(12):1339-43. PubMed ID: 21849968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-thalassemia in blacks: interactions with the sickle hemoglobin gene.
    Steinberg MH; Embury SH
    Birth Defects Orig Artic Ser; 1987; 23(5A):43-8. PubMed ID: 3689929
    [No Abstract]   [Full Text] [Related]  

  • 7. Coagulation activation in sickle cell trait: an exploratory study.
    Amin C; Adam S; Mooberry MJ; Kutlar A; Kutlar F; Esserman D; Brittain JE; Ataga KI; Chang JY; Wolberg AS; Key NS
    Br J Haematol; 2015 Nov; 171(4):638-46. PubMed ID: 26511074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Hb H disease with sickle-trait.
    Martinez G; Ferreira R; Hernandez A; Di Rienzo A; Colombo B
    Hemoglobin; 1986; 10(4):421-5. PubMed ID: 3744872
    [No Abstract]   [Full Text] [Related]  

  • 9. Sickle cell trait, hemoglobin C trait, and invasive pneumococcal disease.
    Poehling KA; Light LS; Rhodes M; Snively BM; Halasa NB; Mitchel E; Schaffner W; Craig AS; Griffin MR
    Epidemiology; 2010 May; 21(3):340-6. PubMed ID: 20220521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated D-dimer levels in African Americans with sickle cell trait.
    Naik RP; Wilson JG; Ekunwe L; Mwasongwe S; Duan Q; Li Y; Correa A; Reiner AP
    Blood; 2016 May; 127(18):2261-3. PubMed ID: 26968536
    [No Abstract]   [Full Text] [Related]  

  • 11. Sickle cell trait, hemoglobin C trait, and Burkitt's lymphoma.
    Nkrumah FK; Perkins IV
    Am J Trop Med Hyg; 1976 Jul; 25(4):633-6. PubMed ID: 961985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of potential thromboembolic, renal and cardiac complications of sickle cell trait.
    Bucknor MD; Goo JS; Coppolino ML
    Hemoglobin; 2014; 38(1):28-32. PubMed ID: 24099594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor V Leiden and prothrombin G20210A variant are risk factors for venous thromboembolism in the Argentinean population.
    Adamczuk Y; Iglesias Varela ML; Forastiero R; Martinuzzo M; Cerrato G; Pombo G; Carreras LO
    Thromb Haemost; 2000 Mar; 83(3):509-10. PubMed ID: 10744162
    [No Abstract]   [Full Text] [Related]  

  • 14. Sickle Cell Trait, Rhabdomyolysis, and Mortality among U.S. Army Soldiers.
    Nelson DA; Deuster PA; Carter R; Hill OT; Wolcott VL; Kurina LM
    N Engl J Med; 2016 Aug; 375(5):435-42. PubMed ID: 27518662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sickle cell trait and aviation.
    Long ID
    Aviat Space Environ Med; 1982 Oct; 53(10):1021-9. PubMed ID: 6184047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboelastographic characterization of the activated clotting system in children with sickle cell trait or sickle cell disease.
    Gupta S; Carmona R; Malvar J; Young G
    Thromb Res; 2017 Mar; 151():44-50. PubMed ID: 28110132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sickle cell trait revisited.
    Harkness DR
    Am J Med; 1989 Sep; 87(3N):30N-34N. PubMed ID: 2486530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of association between the C677T mutation in the 5,10-methylenetetrahydrofolate reductase gene and venous thromboembolism in Northwestern Greece.
    Zalavras ChG; Giotopoulou S; Dokou E; Mitsis M; Ioannou HV; Tzolou A; Kolaitis N; Vartholomatos G
    Int Angiol; 2002 Sep; 21(3):268-71. PubMed ID: 12384649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interrelation of hyperhomocysteinemia and inherited risk factors for venous thromboembolism. Results from the E.D.I.TH. study: a hospital-based case-control study.
    Oger E; Lacut K; Le Gal G; Couturaud F; Abalain JH; Mercier B; Mottier D;
    Thromb Res; 2007; 120(2):207-14. PubMed ID: 17126889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for venous thromboembolism in children.
    Gerotziafas GT
    Int Angiol; 2004 Sep; 23(3):195-205. PubMed ID: 15765033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.